$1.96+0.06 (+3.16%)
Health Catalyst, Inc.
Health Catalyst, Inc. in the Healthcare sector is trading at $1.96 with a market capitalization of $98M. Wall Street consensus targets $1.90 (5 analysts), implying a -3.1% move over the next 12 months. The stock is currently 52% below its 52-week high of $4.12, remaining 6.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $70.76M↓ | $74.68M↓ | $76.32M↓ | $80.72M↑ | $79.41M |
| Gross Profit | $35.46M↓ | $39.38M↑ | $37.82M↓ | $38.24M↑ | $36.23M |
| Operating Income | -$7.16M↓ | $3.26M↑ | -$17.51M↓ | -$8.32M↑ | -$17.02M |
| Net Income | -$111.03M↓ | -$91.03M↓ | -$22.23M↑ | -$40.98M↓ | -$23.74M |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that ...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (NASDAQ:HCAT) and its peers.
A number of stocks fell in the afternoon session after a confluence of high-profile AI talent departures from Alphabet, and a regulatory overhang pulled the entire communication-services and software complex lower.
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Software is rapidly reducing operating expenses for businesses. This secular theme makes SaaS companies attractive investment candidates but also comes with higher valuations that cause volatility. Unfortunately, the rich prices have haunted them over the past six months as the industry has shed 10.4%. This drop is a stark contrast from the S&P 500’s 10.9% gain.
A number of stocks fell in the afternoon session as investors rotated from the high-multiple growth names that led the recent rally.